Study participants are swallowing pills containing gene-modified E. coli bacteria designed to absorb excess ammonia in the body.
Healthcare is changing around the world. The very definition of medicine is now up for debate. Across digital health, biotechnology, and the medical device sector, startups are finally bringing medicine into the 21st century. In this report we take a look at cutting edge developments in healthcare, and the startups behind them that are just beginning to impact the world.
Scientists screened a library of 100 million antibodies to find several that offer an easier way to reprogram adult cells into stem cells.
This dime-sized chip transforms cells from one type to another with a small electrical pulse – creating a non-invasive, instantaneous way to repair injured tissue.
Exposure to indole compounds produced by E coli bacteria helped certain animals stay active and mobile at advanced ages – paving the way for new drugs that could help humans live well into old age.
Spiders that ingested graphene and carbon nanotubes produced silk that was tougher than Kevlar – potentially paving the way for a new class of high-performing bio-enhanced materials.
Invasive bone grafts may be on the way out: A new gene therapy procedure using gas-filled microbubbles healed fractures in just 8 weeks.
These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others.
We used the CB Insights database to identify companies that are using AI to expedite various stages of the clinical trial process, from drug formulation to patient recruitment.